Man Group PLC Coherus Bio Sciences, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $203,047 - $359,347	35,685 New	35,685 $282,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $1.49 Million - $1.7 Million	-89,993 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $364,043 - $415,899	20,910 Added 30.27%	89,993 $1.65 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $745,785 - $990,246	51,683 Added 297.03%	69,083 $1.23 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $203,058 - $392,022	17,400 New	17,400 $282,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.